Suppr超能文献

质子射程不确定性降低对颅底肿瘤的正常组织并发症概率(NTCP)和健康组织剂量的获益。

Proton range uncertainty reduction benefits for skull base tumors in terms of normal tissue complication probability (NTCP) and healthy tissue doses.

机构信息

Department of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München, Garching, Germany.

Division of Radiation Biophysics, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Med Phys. 2021 Sep;48(9):5356-5366. doi: 10.1002/mp.15097. Epub 2021 Jul 29.

Abstract

PURPOSE

Proton therapy allows for more conformal dose distributions and lower organ at risk and healthy tissue doses than conventional photon-based radiotherapy, but uncertainties in the proton range currently prevent proton therapy from making full use of these advantages. Numerous developments therefore aim to reduce such range uncertainties. In this work, we quantify the benefits of reductions in range uncertainty for treatments of skull base tumors.

METHODS

The study encompassed 10 skull base patients with clival tumors. For every patient, six treatment plans robust to setup errors of 2 mm and range errors from 0% to 5% were created. The determined metrics included the brainstem and optic chiasm normal tissue complication probability (NTCP) with the endpoints of necrosis and blindness, respectively, as well as the healthy tissue volume receiving at least 70% of the prescription dose.

RESULTS

A range uncertainty reduction from the current level of 4% to a potentially achievable level of 1% reduced the probability of brainstem necrosis by up to 1.3 percentage points in the nominal scenario in which neither setup nor range errors occur and by up to 2.9 percentage points in the worst-case scenario. Such a range uncertainty reduction also reduced the optic chiasm NTCP with the endpoint of blindness by up to 0.9 percentage points in the nominal scenario and by up to 2.2 percentage points in the worst-case scenario. The decrease in the healthy tissue volume receiving at least 70% of the prescription dose ranged from -7.8 to 24.1 cc in the nominal scenario and from -3.4 to 38.4 cc in the worst-case scenario.

CONCLUSION

The benefits quantified as part of this study serve as a guideline of the OAR and healthy tissue dose benefits that range monitoring techniques may be able to achieve. Benefits were observed between all levels of range uncertainty. Even smaller range uncertainty reductions may therefore be beneficial.

摘要

目的

与传统基于光子的放射治疗相比,质子治疗可以实现更适形的剂量分布,降低危及器官和健康组织的剂量,但目前质子射程的不确定性阻碍了质子治疗充分利用这些优势。因此,许多研究旨在降低这种射程不确定性。在这项工作中,我们量化了降低射程不确定性对颅底肿瘤治疗的益处。

方法

该研究包括 10 例颅底斜坡肿瘤患者。每位患者均创建了 6 种治疗计划,这些计划对 2mm 的摆位误差和 0%至 5%的射程误差具有稳健性。所确定的指标包括脑干和视交叉正常组织并发症概率(NTCP),终点分别为坏死和失明,以及至少接收 70%处方剂量的健康组织体积。

结果

与当前 4%的射程不确定性相比,潜在可达到 1%的射程不确定性降低,在既没有摆位误差也没有射程误差的名义情况下,脑干坏死的概率最高降低了 1.3 个百分点,在最坏情况下最高降低了 2.9 个百分点。这种射程不确定性降低也降低了视交叉 NTCP,在名义情况下失明的终点降低了最高 0.9 个百分点,在最坏情况下降低了 2.2 个百分点。在名义情况下,至少接收 70%处方剂量的健康组织体积减少了 7.8 至 24.1cc,在最坏情况下减少了 3.4 至 38.4cc。

结论

作为这项研究的一部分,所量化的益处可作为 OAR 和健康组织剂量的益处指南,这些益处可能是通过范围监测技术实现的。在所有射程不确定性水平都观察到了益处。因此,即使是更小的射程不确定性降低也可能是有益的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验